The spelling of "Aurintricarboxylic Acid Trisodium Salt" can be daunting due to its length and intricate composition. However, breaking it down using IPA phonetic transcription can make it more manageable. The word is pronounced ɔːrɪntraɪˌkɑːbɒksɪlɪk ˈæsɪd traɪˌsəʊdɪəm sɔːlt. This breaks down the pronunciation of each syllable, making it easier to sound out. Understanding IPA can be a useful tool for tackling complex words, especially in the fields of science and medicine where lengthy terminology is commonplace.
Aurintricarboxylic Acid Trisodium Salt is a chemical compound primarily used in research and biological applications. It is a trisodium salt of aurintricarboxylic acid, which is a synthetic molecule derived from aurin, a yellow dye derived from coal tar.
Aurintricarboxylic Acid Trisodium Salt is a yellowish powder that is soluble in water. Its chemical formula is C22H14N3Na3O14, and it has a molecular weight of approximately 651.32 g/mol. This compound is often referred to by its abbreviation, ATA, in scientific literature.
In research, Aurintricarboxylic Acid Trisodium Salt is primarily used as an inhibitor of protein-nucleic acid interactions. It can bind to nucleic acids and certain proteins, obstructing their functions and interfering with processes such as DNA replication, transcription, and protein synthesis. Due to its ability to inhibit DNA and RNA polymerases, ATA has been widely used to study the mechanisms of various biological processes.
Aurintricarboxylic Acid Trisodium Salt has also been investigated for its antiviral and anticancer properties. It has shown promising results in inhibiting the replication of various viruses, including HIV and herpes simplex virus. Additionally, ATA has demonstrated cytotoxic effects on cancer cells in preclinical studies.
In conclusion, Aurintricarboxylic Acid Trisodium Salt is a yellow powder utilized in scientific research due to its inhibitory properties on protein-nucleic acid interactions. It has potential applications in studying biological processes, antiviral research, and cancer therapeutics.